Jansén CT, Heredity of chronic polymorphous light eruptions, in Arch Dermatol, vol. 114, n. 2, February 1978, pp. 188–90, PMID629543.
Dawe RS, Collins P, Ferguson J, O'Sullivan A, Actinic prurigo and HLA-DR4, in J. Invest. Dermatol., vol. 108, n. 2, February 1997, pp. 233–4, PMID9008241.
Grabczynska SA, McGregor JM, Kondeatis E, Vaughan RW, Hawk JL, Actinic prurigo and polymorphic light eruption: common pathogenesis and the importance of HLA-DR4/DRB1*0407, in Br. J. Dermatol., vol. 140, n. 2, February 1999, pp. 232–6, PMID10233214.
Hasan T, Ranki A, Jansen CT, Karvonen J, Disease associations in polymorphous light eruption. A long-term follow-up study of 94 patients, in Arch Dermatol, vol. 134, n. 9, September 1998, pp. 1081–5, PMID9762018.
Norris PG, Morris J, McGibbon DM, Chu AC, Hawk JL, Polymorphic light eruption: an immunopathological study of evolving lesions, in Br. J. Dermatol., vol. 120, n. 2, February 1989, pp. 173–83, PMID2923793.
González-Amaro R, Baranda L, Salazar-Gonzalez JF, Abud-Mendoza C, Moncada B, Immune sensitization against epidermal antigens in polymorphous light eruption, in J. Am. Acad. Dermatol., vol. 24, n. 1, January 1991, pp. 70–3, PMID1999534.
Ros AM, Solar purpura--an unusual manifestation of polymorphous light eruption, in Photodermatol, vol. 5, n. 1, February 1988, pp. 47–8, PMID3353316.
Kalivas J, Kalivas L, Solar purpura appearing in a patient with polymorphous light eruption, in Photodermatol Photoimmunol Photomed, vol. 11, n. 1, February 1995, pp. 31–2, PMID7654565.
Elpern DJ, Morison WL, Hood AF, Papulovesicular light eruption. A defined subset of polymorphous light eruption, in Arch Dermatol, vol. 121, n. 10, October 1985, pp. 1286–8, PMID4037822.
(DE) Lehmann P, Fritsch C, Neumann NJ, [Photodiagnostic tests. 2: Photoprovocation tests], in Hautarzt, vol. 51, n. 6, June 2000, pp. 449–59; quiz 457–9, PMID10907165.
Thune P, Contact and photocontact allergy to sunscreens, in Photodermatol, vol. 1, n. 1, February 1984, pp. 5–9, PMID6335754.
Murphy GM, Hawk JL, The prevalence of antinuclear antibodies in patients with apparent polymorphic light eruption, in Br. J. Dermatol., vol. 125, n. 5, November 1991, pp. 448–51, PMID1751350.
Man I, Dawe RS, Ferguson J, Artificial hardening for polymorphic light eruption: practical points from ten years' experience, in Photodermatol Photoimmunol Photomed, vol. 15, n. 3-4, 1999, pp. 96–9, PMID10404717.
Patel DC, Bellaney GJ, Seed PT, McGregor JM, Hawk JL, Efficacy of short-course oral prednisolone in polymorphic light eruption: a randomized controlled trial, in Br. J. Dermatol., vol. 143, n. 4, October 2000, pp. 828–31, PMID11069465.
Norris PG, Hawk JL, Successful treatment of severe polymorphous light eruption with azathioprine, in Arch Dermatol, vol. 125, n. 10, October 1989, pp. 1377–9, PMID2802645.
Shipley DR, Hewitt JB, Polymorphic light eruption treated with cyclosporin, in Br. J. Dermatol., vol. 144, n. 2, February 2001, pp. 446–7, PMID11251609.
Leroy D, Dompmartin A, Faguer K, Michel M, Verneuil L, Polychromatic phototest as a prognostic tool for polymorphic light eruption, in Photodermatol Photoimmunol Photomed, vol. 16, n. 4, August 2000, pp. 161–6, PMID11019940.